Takeda reported a 30% rise in Q1 profit and beat EPS estimates, offsetting Vyvanse losses with growth in oncology, plasma, ...

Teva Pharmaceutical Industries TEVA reported second-quarter 2025 adjusted earnings of 66 cents per share, which beat the ...

Sun Pharmaceutical Industries Ltd. settled claims worth $200 million in an antitrust case in Pennsylvania alleging that the ...

Cipla reports a 10% YoY rise in Q1FY26 net profit, driven by strong performance in consumer healthcare and generics. The ...

Ajanta Pharma reported a 4% year-on-year increase in its consolidated profit after tax, reaching Rs 255 crore for the first ...

A new report has drawn attention to the growing number of prescription drugs being excluded from commercial insurance ...

As of 2024, Brazil's Semaglutide market was estimated at $581 million. The global market size for the GLP-1 (glucagon-like ...

CHENNAI: India's pharmaceutical exports reached US$30.5 billion in FY2025, marking a 9.3% increase from the previous year, ...

The drugmaker plans to launch Semaglutide in 87 countries next year, including those where patents are expiring and emerging ...

Graeme Duncan from ADVANZ PHARMA explores how successful cross-industry collaboration between pharma and generics companies has helped support supply challenges during the pandemic.

Indian pharma is hoping to cash in. Generic firms, such as Biocon, are already offering weight-loss drugs, such as cheaper ...

Says “exciting time” for biosimilars. Sees ~$700M of net savings by 2027 with two thirds expected to be realized by 2026. Expects portfolio to ...